Menarini Silicon Biosystems's CELLSEARCH(R) CMMC and HER2-CTC ... - 14 October 2022 00:00

HUNTINGDON VALLEY, Pa., Oct. 13, 2022 /PRNewswire-AsiaNet/ -- These new codes are required to access Medicare/Medicaid insurance reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and HER2 Circulating Tumor Cell (CTC-HER2) assays, to monitor disease status in patients with life-threa...

  Novavax Prototype COVID-19 Vaccine Data Support Homologous and... - 13 October 2022 01:09

GAITHERSBURG, Md., Oct. 12, 2022 /PRNewswire-AsiaNet/ -- -- Homologous boosting with the prototype Novavax COVID-19 vaccine induced robust antibody titers for Omicron BA.1, BA.2, and BA.5 -- Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine...

  Ascend continues broad expansion into new markets, launches Hi... - 12 October 2022 03:34

HOUSTON, Oct. 12, 2022 /PRNewswire-AsiaNet/ -- Ascend Performance Materials today announced a new portfolio of medical grade nylon 6,6 resins and engineered materials for the healthcare market under its HiDura( https://c212.net/c/link/?t=0&l=en&o=3673437-1&h=3917527930&u=https%3A%2F%2Fwww.asce...

  CSafe and BioLife Solutions, Inc. announce partnership to expa... - 11 October 2022 23:15

MONROE, Ohio and BOTHELL, Wash., Oct. 11, 2022 /PRNewswire-AsiaNet/ -- -- CSafe joins BioLife's global partner network of cold chain solution providers using the evo (R) cold chain management platform CSafe, one of the largest active and passive temperature-controlled shipping solutions providers for pharmaceutica...

  Digital private bank becomes reality - Alpian launches as Swit... - 11 October 2022 17:00

GENEVA, Oct. 11, 2022 /PRNewswire-AsiaNet/ -- Alpian SA (Alpian) is proud to announce the opening of the first Swiss digital private bank designed to cater specifically to the needs of the mass affluent client segment. Its mobile-first digital service, which combines everyday and private bank...

  Pharming submits a Marketing Authorisation Application to the ... - 11 October 2022 16:00

LEIDEN, Netherlands, Oct. 11, 2022 /PRNewswire-AsiaNet/ -- -- Application is based on randomized, controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency -- This submission follows the grant of accelerated assessment allowing an expedited review ...

  Translumina further strengthens senior leadership to drive nex... - 11 October 2022 01:29

NEW DELHI, Oct. 10, 2022 /PRNewswire-Asianet/ Translumina - a global developer and manufacturer of innovative cardiovascular medical devices, implants and access products - appointed Indranil Mukherjee as Group CEO and Armin Kiser as Managing Director and Chief Operating Officer for the c...

  Pierre Fabre is taking a minority stake, via its dedicated inv... - 10 October 2022 18:00

CASTRES, France and VITROLLES, France, October 10, 2022, PRNewswire-AsiaNet/-- Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets. - Gennisium finds a strategic ...

  On World Mental Health Day, NCCN Announces Free Updated Distre... - 10 October 2022 10:34

PLYMOUTH MEETING, Pa., Oct. 10, 2022 /PRNewswire-AsiaNet/ -- -- The National Comprehensive Cancer Network's Distress Thermometer helps people with cancer worldwide receive better care by empowering discussion and recommending best practices for managing psychological wellness. The National Comprehensive ...

  Mediterranean diet improves immunotherapy response rates and p... - 09 October 2022 09:01

VIENNA Oct. 8, 2022 /PRNewswire-AsiaNet/ Eating a Mediterranean diet, rich in fibre, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunotherapy response rates and progression-free survival in advanced melanoma patients, a new study presented today at UE...